West Pharma (WST) Misses Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $362.31 -1.17%
Revenue Growth %: +2.6%
Financial Fact:
Income tax expense: 14.4M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +2.6%
Financial Fact:
Income tax expense: 14.4M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
West Pharma (NYSE: WST) reported Q4 EPS of $0.54, $0.02 worse than the analyst estimate of $0.56. Revenue for the quarter came in at $382.3 million versus the consensus estimate of $387.31 million.
For earnings history and earnings-related data on West Pharma (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Element Solutions (ESI) PT Lowered to $47 at UBS, Buy Rating Maintained
- Barclays says AI trade is maturing, favors greater diversification
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
